Sunday 6 June 2021

Canada secures more Pfizer shots as focus shifts to second doses


CBC News shows that Prime Minister Justin Trudeau announced that the government will buy 3 million more vaccine doses from Pfizer than originally planned, and will also try to firm up Moderna supply via the USA, instead of Europe.

Pfizer Inc. is an American multinational pharmaceutical corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues. In 2020, 52% of the company's revenues came from the United States, 6% came from each of China and Japan, and 36% came from other countries.

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on vaccine technologies based on messenger RNA (mRNA). Moderna's vaccine platform inserts synthetic nucleoside-modified messenger RNA (modRNA) into human cells using a coating of lipid nanoparticles. This mRNA then reprograms the cells to prompt immune responses. Moderna develops mRNA therapeutic vaccines that are delivered in lipid nanoparticle, using mRNA with pseudouridine nucleosides. Candidates are designed to have improved folding and translation efficiency via insertional mutagenesis. The company's only commercial product right now is the Moderna COVID-19 vaccine.

No comments:

Post a Comment